Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RPL3L | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
mRNA | HIF1AN | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
mRNA | ADGRF4 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | GDPD5 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
mRNA | TFR2 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
mRNA | TTI2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | CIR1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
mRNA | UBR4 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
mRNA | CA13 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
mRNA | STXBP5 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |